HER2-positive metastatic breast cancermetastatic breast cancerHER2-low metastatic breast cancerHER2-low diseaseunresectable or metastatic breast cancerHER2-low unresectable or metastatic breast cancerHER2-positive unresectable or metastatic breast cancerHER2-positive diseaseT-DXdTrastuzumab deruxtecan
…n (T-DXd) is an antibody–drug conjugate with proven efficacy in HER2-positive metastatic breast cancer and, more recently, in HER2-low disease. However, real-world da…